scholarly journals Restless Legs Syndrome: Known Knowns and Known Unknowns

2022 ◽  
Vol 12 (1) ◽  
pp. 118
Author(s):  
Elena Antelmi ◽  
Lorenzo Rocchi ◽  
Anna Latorre ◽  
Daniele Belvisi ◽  
Francesca Magrinelli ◽  
...  

Although restless legs syndrome (RLS) is a common neurological disorder, it remains poorly understood from both clinical and pathophysiological perspectives. RLS is classified among sleep-related movement disorders, namely, conditions characterized by simple, often stereotyped movements occurring during sleep. However, several clinical, neurophysiological and neuroimaging observations question this view. The aim of the present review is to summarize and query some of the current concepts (known knowns) and to identify open questions (known unknowns) on RLS pathophysiology. Based on several lines of evidence, we propose that RLS should be viewed as a disorder of sensorimotor interaction with a typical circadian pattern of occurrence, possibly arising from neurochemical dysfunction and abnormal excitability in different brain structures.

2021 ◽  
Vol 14 (9) ◽  
pp. e244890
Author(s):  
Ulrich Moser ◽  
Jasmin Schwab

Restless legs syndrome (RLS) is a common neurological disorder characterised by an irresistible urge to move the lower limbs, often accompanied by unpleasant sensations in the legs, typically occurring in the evening and at night and improving with movement. Restless arms syndrome (RAS) predominantly affects the arms, while the legs are rarely affected. RAS appears to be very rare, with very few cases described to date, but the diagnosis of RAS is probably made too infrequently, especially for milder and transient forms. The patient reported here even had severe symptoms for years that could have indicated RAS. He observed an immediate improvement in all RAS-related symptoms after administration of 100 mg L-dopa +25 mg benserazide, which continues to this day. Clinicians should always be alert for RLS-like symptoms in one or both arms that worsen at rest and improve with movement, thinking of possible RAS.


2018 ◽  
Vol 9 ◽  
Author(s):  
Marco Hermesdorf ◽  
Benedikt Sundermann ◽  
Rajesh Rawal ◽  
András Szentkirályi ◽  
Udo Dannlowski ◽  
...  

Author(s):  
Sathiji Nageshwaran ◽  
Heather C Wilson ◽  
Anthony Dickenson ◽  
David Ledingham

This chapter discusses the clinical features and evidence-based pharmacological management of tremor, dystonia (focal, generalized, and dopa-responsive dystonia), tics and Tourette’s syndrome, chorea (Huntington’s disease (HD) and Sydenham’s chorea), ballism and athetosis, myoclonus, and restless legs syndrome (RLS).


2016 ◽  
pp. 613-615
Author(s):  
Birgit Högl ◽  
Birgit Frauscher ◽  
Claudio Podesta

Sign in / Sign up

Export Citation Format

Share Document